MGO One Seven’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.82M | Sell |
20,123
-2,802
| -12% | -$527K | 0.06% | 337 |
|
|
2026
Q1 | $4.52M | Sell |
22,925
-2,601
| -10% | -$502K | 0.09% | 255 |
|
|
2025
Q4 | $4.69M | Buy |
25,526
+2,314
| +10% | +$406K | 0.1% | 243 |
|
|
2025
Q3 | $3.56M | Buy |
23,212
+2,619
| +13% | +$396K | 0.08% | 269 |
|
|
2025
Q2 | $2.88M | Sell |
20,593
-360
| -2% | -$50.5K | 0.09% | 246 |
|
|
2025
Q1 | $3.08M | Buy |
20,953
+1,984
| +10% | +$287K | 0.12% | 186 |
|
|
2024
Q4 | $2.49M | Buy |
18,969
+10,989
| +138% | +$1.54M | 0.1% | 237 |
|
|
2024
Q3 | $1.24M | Sell |
7,980
-327
| -4% | -$52.8K | 0.05% | 352 |
|
|
2024
Q2 | $1.3M | Buy |
8,307
+803
| +11% | +$121K | 0.06% | 319 |
|
|
2024
Q1 | $1.02M | Buy |
7,504
+1,039
| +16% | +$138K | 0.05% | 343 |
|
|
2023
Q4 | $871K | Buy |
6,465
+3,459
| +115% | +$450K | 0.05% | 357 |
|
|
2023
Q3 | $407K | Buy |
3,006
+1,089
| +57% | +$149K | 0.03% | 510 |
|
|
2023
Q2 | $274K | Sell |
1,917
-131
| -6% | -$19.3K | 0.03% | 629 |
|
|
2023
Q1 | $284K | Buy |
2,048
+239
| +13% | +$32.2K | 0.02% | 689 |
|
|
2022
Q4 | $245K | Buy |
+1,809
| New | +$227K | 0.02% | 617 |
|
|
2022
Q3 | – | Sell |
-2,517
| Closed | -$333K | – | 718 |
|
|
2022
Q2 | $333K | Sell |
2,517
-5,025
| -67% | -$659K | 0.05% | 432 |
|
|
2022
Q1 | $1M | Sell |
7,542
-48
| -0.6% | -$5.76K | 0.11% | 210 |
|
|
2021
Q4 | $884K | Buy |
7,590
+286
| +4% | +$33.7K | 0.09% | 249 |
|
|
2021
Q3 | $911K | Buy |
+7,304
| New | +$850K | 0.12% | 218 |
|
|
2021
Q2 | – | Sell |
-4,846
| Closed | -$481K | – | 592 |
|
|
2021
Q1 | $481K | Sell |
4,846
-300
| -6% | -$30.2K | 0.08% | 305 |
|
|
2020
Q4 | $532K | Sell |
5,146
-760
| -13% | -$80.5K | 0.11% | 243 |
|
|
2020
Q3 | $644K | Buy |
+5,906
| New | +$657K | 0.15% | 172 |
|
|
2020
Q1 | – | Sell |
-4,762
| Closed | -$474K | – | 403 |
|
|
2019
Q4 | $474K | Buy |
4,762
+2,192
| +85% | +$206K | 0.12% | 227 |
|
|
2019
Q3 | $229K | Sell |
2,570
-1
| -0% | -$87 | 0.07% | 370 |
|
|
2019
Q2 | $212K | Buy |
+2,571
| New | +$202K | 0.07% | 360 |
|
|
2019
Q1 | – | Sell |
-1,597
| Closed | -$121K | – | 511 |
|
|
2018
Q4 | $121K | Buy |
+1,597
| New | +$125K | 0.05% | 413 |
|
|
2018
Q1 | $581K | Sell |
8,304
-639
| -7% | -$44.3K | 0.27% | 103 |
|
|
2017
Q4 | $621K | Buy |
+8,943
| New | +$603K | 0.29% | 92 |
|
Other funds holding AZN
EP
IA
MGO One Seven's AZN Position: Q2 2026 in Review
MGO One Seven reduced its AstraZeneca (AZN) stake by 12% in Q2 2026, selling an estimated $527K and leaving 20,123 shares worth $3.82M. The position accounts for 0.06% of the portfolio, ranked #337.
MGO One Seven first reported a position in AZN in Q4 2017 and has held it in 28 quarters since. The position peaked at $4.69M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- MGO One Seven held 20,123 shares of AstraZeneca worth $3.82M as of Q2 2026.
- MGO One Seven sold 2,802 AstraZeneca shares in Q2 2026, an estimated $527K.
- AstraZeneca made up 0.06% of MGO One Seven's portfolio in Q2 2026, its #337 holding.
- MGO One Seven first reported a position in AstraZeneca in Q4 2017 and has held it in 28 quarters since.
- MGO One Seven's AstraZeneca position peaked at $4.69M in Q4 2025.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.